
Chemometec A/S
CSE:CHEMM

Chemometec A/S?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
354.2
610.5
|
Price Target |
|
We'll email you a reminder when the closing price reaches DKK.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Chemometec A/S hold over its rivals?
What risks and challenges
does Chemometec A/S face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Chemometec A/S.
Provide an overview of the primary business activities
of Chemometec A/S.
What unique competitive advantages
does Chemometec A/S hold over its rivals?
What risks and challenges
does Chemometec A/S face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Chemometec A/S.
Provide P/S
for Chemometec A/S.
Provide P/E
for Chemometec A/S.
Provide P/OCF
for Chemometec A/S.
Provide P/FCFE
for Chemometec A/S.
Provide P/B
for Chemometec A/S.
Provide EV/S
for Chemometec A/S.
Provide EV/GP
for Chemometec A/S.
Provide EV/EBITDA
for Chemometec A/S.
Provide EV/EBIT
for Chemometec A/S.
Provide EV/OCF
for Chemometec A/S.
Provide EV/FCFF
for Chemometec A/S.
Provide EV/IC
for Chemometec A/S.
Show me price targets
for Chemometec A/S made by professional analysts.
What are the Revenue projections
for Chemometec A/S?
How accurate were the past Revenue estimates
for Chemometec A/S?
What are the Net Income projections
for Chemometec A/S?
How accurate were the past Net Income estimates
for Chemometec A/S?
What are the EPS projections
for Chemometec A/S?
How accurate were the past EPS estimates
for Chemometec A/S?
What are the EBIT projections
for Chemometec A/S?
How accurate were the past EBIT estimates
for Chemometec A/S?
Compare the revenue forecasts
for Chemometec A/S with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Chemometec A/S and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Chemometec A/S against its competitors.
Analyze the profit margins
(gross, operating, and net) of Chemometec A/S compared to its peers.
Compare the P/E ratios
of Chemometec A/S against its peers.
Discuss the investment returns and shareholder value creation
comparing Chemometec A/S with its peers.
Analyze the financial leverage
of Chemometec A/S compared to its main competitors.
Show all profitability ratios
for Chemometec A/S.
Provide ROE
for Chemometec A/S.
Provide ROA
for Chemometec A/S.
Provide ROIC
for Chemometec A/S.
Provide ROCE
for Chemometec A/S.
Provide Gross Margin
for Chemometec A/S.
Provide Operating Margin
for Chemometec A/S.
Provide Net Margin
for Chemometec A/S.
Provide FCF Margin
for Chemometec A/S.
Show all solvency ratios
for Chemometec A/S.
Provide D/E Ratio
for Chemometec A/S.
Provide D/A Ratio
for Chemometec A/S.
Provide Interest Coverage Ratio
for Chemometec A/S.
Provide Altman Z-Score Ratio
for Chemometec A/S.
Provide Quick Ratio
for Chemometec A/S.
Provide Current Ratio
for Chemometec A/S.
Provide Cash Ratio
for Chemometec A/S.
What is the historical Revenue growth
over the last 5 years for Chemometec A/S?
What is the historical Net Income growth
over the last 5 years for Chemometec A/S?
What is the current Free Cash Flow
of Chemometec A/S?
Discuss the annual earnings per share (EPS)
trend over the past five years for Chemometec A/S.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
DK |
![]() |
Chemometec A/S
CSE:CHEMM
|
8.9B DKK | 37.9 | |
US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1T USD | 1 236.8 |
|
US |
![]() |
Thermo Fisher Scientific Inc
NYSE:TMO
|
152.9B USD | 16.5 |
|
US |
![]() |
Danaher Corp
NYSE:DHR
|
134.6B USD | 19.8 |
|
KR |
![]() |
Samsung Biologics Co Ltd
KRX:207940
|
71.2T KRW | 32.3 |
|
CH |
![]() |
Lonza Group AG
SIX:LONN
|
39B CHF | 22.5 |
|
CN |
![]() |
WuXi AppTec Co Ltd
SSE:603259
|
239B CNY | 20.7 |
|
US |
![]() |
Agilent Technologies Inc
NYSE:A
|
31.8B USD | 18.6 |
|
US |
![]() |
IQVIA Holdings Inc
NYSE:IQV
|
27.7B USD | 11.5 |
|
US |
![]() |
Mettler-Toledo International Inc
NYSE:MTD
|
24.2B USD | 21.2 |
|
FR |
![]() |
Sartorius Stedim Biotech SA
PAR:DIM
|
16.8B EUR | 26.6 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
DK |
![]() |
Chemometec A/S
CSE:CHEMM
|
Average EV/EBITDA:
133.1
37.9
|
25%
|
1.5 | |
US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1 236.8
|
7%
|
176.7 |
|
US |
![]() |
Thermo Fisher Scientific Inc
NYSE:TMO
|
16.5
|
6%
|
2.7 |
|
US |
![]() |
Danaher Corp
NYSE:DHR
|
19.8
|
7%
|
2.8 |
|
KR |
![]() |
Samsung Biologics Co Ltd
KRX:207940
|
32.3
|
17%
|
1.9 |
|
CH |
![]() |
Lonza Group AG
SIX:LONN
|
22.5
|
18%
|
1.3 |
|
CN |
![]() |
WuXi AppTec Co Ltd
SSE:603259
|
20.7
|
24%
|
0.9 |
|
US |
![]() |
Agilent Technologies Inc
NYSE:A
|
18.6
|
10%
|
1.9 |
|
US |
![]() |
IQVIA Holdings Inc
NYSE:IQV
|
11.5
|
9%
|
1.3 |
|
US |
![]() |
Mettler-Toledo International Inc
NYSE:MTD
|
21.2
|
4%
|
5.3 |
|
FR |
![]() |
Sartorius Stedim Biotech SA
PAR:DIM
|
26.6
|
20%
|
1.3 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.